Variable | Frequency (%) |
---|---|
Ever encounter adverse drug reaction (ADR) at health facility (n = 80) | |
Yes | 47 (58.8) |
No | 33 (41.2) |
Measure(s) taken in the case of encountered ADRs (n = 92)a | |
Refer to a secondary health facility | 50 (54.3) |
Treat symptoms with another drug | 30 (32.6) |
Provide counselling to patients | 7 (7.6) |
Stop the use of the drug | 5 (5.4) |
Ever come across ADR reporting form (n = 80) | |
Yes | 30 (37.5) |
No | 50 (62.5) |
Is ADR reporting form available in your facility? (n = 80) | |
Yes | 17 (21.3) |
No | 63 (78.8) |
Barrier(s) in obtaining the ADR reporting form (n = 17) | |
No known source of obtaining the form | 9 (5.3) |
No proper distribution of form | 4 (2.4) |
Not the duty of primary healthcare | 4 (2.4) |
Who should report ADRs? (n = 91)a | |
Any healthcare worker | 50 (71.4) |
Patients | 26 (28.6) |
Only senior healthcare worker | 15 (16.5) |
Ever received training on pharmacovigilance and/or ADR reporting? (n = 80) | |
Yes | 11 (13,8) |
No | 69 (86.2) |
Opinion on willingness to receive training (n = 80) | |
Yes | 73 (91.2) |
No | 7 (8.8) |
Self-rating score on interest to undergo training in pharmacovigilance (n = 73) | |
< 5 | 0 (0.0) |
5–7 | 8 (11.0) |
8–10 | 65 (89.0) |
Reasons for the interest to undergo pharmacovigilance training (n = 80) | |
Acquire more knowledge on ADRs and reporting | 56 (70.0) |
Know more about the detection, assessment and prevention of ADRs | 15 (18.7) |
Patient care and safety | 4 (5.0) |
Easy access to ADR reports and early treatment of ADRs | 3 (3.8) |
More knowledge on ADRs, especially on how to fill the form | 2 (2.5) |
Regulatory bodies responsible for monitoring ADRs (n = 138)a | |
NAFDAC | 46 (33.3) |
PCN | 35 (25.4) |
FMOH | 30 (21.7) |
WHO | 27 (19.6) |